Clinical Trial Update: Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) [Phase 4]

View source ↗

Summary

Phase 4 SOUL trial evaluating post-surgical Myfembree versus standard of care has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Uterine Fibroids

Drugs mentioned

• MYFEMBREE (relugolix, estradiol hemihydrate, and norethindrone acetate)

Snippet

Sponsor: University of Chicago | Conditions: Metrorrhagia, Pelvic Pain | Phase 4 | Status: WITHDRAWN